Kanamycin Antikörper

Produktnummer ABIN1045821

Produktdetails anti-Kanamycin Antikörper

Target: Kanamycin

Reaktivität: Chemical

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Kanamycin Antikörper ist unkonjugiert

Applikation: ELISA

Kreuzreaktivität (Details): No significant cross-reactivity or interference was observed

Aufreinigung: Protein G purified

Reinheit: > 95 %

Immunogen: Kanamycin-BSA conjugate

Klon: 3F7C11

Isotyp: IgG1, IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid freeze and thaw cycles.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Referenzen für anti-Kanamycin Antikörper (ABIN1045821)

Pietschmann, Dittmann, Spiegel, Krause, Schröper: "A Novel Method for Antibiotic Detection in Milk Based on Competitive Magnetic Immunodetection." in: Foods (Basel, Switzerland), Vol. 9, Issue 12, (2020) (PubMed).

Jin, Jang, Han, Lee: "Development of immunoassays for the detection of kanamycin in veterinary fields." in: Journal of veterinary science, Vol. 7, Issue 2, pp. 111-7, (2006) (PubMed).

DeCastro, Place, Lam, Patel: "Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay." in: Antimicrobial agents and chemotherapy, Vol. 29, Issue 6, pp. 961-4, (1986) (PubMed).

Kubo, Kobayashi, Nishikawa: "Rapid method for determination of kanamycin and dibekacin in serum by use of high-pressure liquid chromatography." in: Antimicrobial agents and chemotherapy, Vol. 28, Issue 4, pp. 521-3, (1986) (PubMed).

Kitagawa, Fujiwara, Tomonoh, Takahashi, Koida: "Enzyme immunoassays of kanamycin group antibiotics with high sensitivities using anti-kanamycin as a common antiserum: reasoning and selection of a heterologous enzyme label." in: Journal of biochemistry, Vol. 94, Issue 4, pp. 1165-72, (1984) (PubMed).

Finitzo-Hieber, McCracken, Roeser, Allen, Chrane, Morrow: "Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study." in: Pediatrics, Vol. 63, Issue 3, pp. 443-50, (1979) (PubMed).

Details zu Kanamycin

Target: Kanamycin

Abstract: Kanamycin Produkte

Substanzklasse: Chemical

Hintergrund: Amkin, biograncetin, enterokan